Patient
SITE011-0175
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE011 (ITA) (Dr. Jansen)
consented 2026-03-25
Adverse events
4
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 4
Grade 2 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-15 (study day 131); relationship: not assessed
Grade 1 Aspartate aminotransferase increased — outcome: RECOVERED/RESOLVED; onset 2022-12-18 (study day 72); relationship: not assessed
Grade 2 Colitis — outcome: RECOVERED/RESOLVED; onset 2022-11-22 (study day 46); relationship: not assessed
Grade 2 Alanine aminotransferase increased — outcome: RECOVERED/RESOLVED; onset 2022-11-18 (study day 42); relationship: RELATED
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.